Molecular characterization of an epidemic clone of panantibiotic-resistant Pseudomonas aeruginosa

Journal of Clinical Microbiology

Volumn 43, Issue 3, 2005, Pages 1198-1204

  Deplano, A ^a   Denis, O ^a   Poirel, L ^b   Hocquet, D ^c   Nonhoff, C ^a   Byl, B ^a   Nordmann, P ^b   Vincent, J L ^a   Struelens, M J ^a  

^a ERASME HOSPITAL   (Belgium)

^b BICÊTRE HOSPITAL   (France)

^c UNIVERSITY HOSPITAL JEAN MINJOZ   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AMINOGLYCOSIDE; AZTREONAM; BETA LACTAMASE; BETA LACTAMASE AMPC; CARBAPENEM; CEFEPIME; CEFTAZIDIME; CEPHALOSPORIN; CEPHALOSPORINASE; CIPROFLOXACIN; COLISTIN; GENTAMICIN; ISEPAMICIN; MEROPENEM; PENICILLIN G; PIPERACILLIN; PIPERACILLIN PLUS TAZOBACTAM; PORIN; QUINOLONE DERIVATIVE; TIMENTIN; TOBRAMYCIN;

AMPLIFIED FRAGMENT LENGTH POLYMORPHISM; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL COLONIZATION; CONTROLLED STUDY; EPIDEMIC; INFECTION CONTROL; INTENSIVE CARE UNIT; MOLECULAR CLONING; MORBIDITY; MORTALITY; NONHUMAN; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; PULSED FIELD GEL ELECTROPHORESIS; PUMP; SEROTYPING; UNIVERSITY HOSPITAL; UPREGULATION;

BETA-LACTAMASES; CROSS INFECTION; DISEASE OUTBREAKS; DRUG RESISTANCE, MULTIPLE, BACTERIAL; ELECTROPHORESIS, GEL, PULSED-FIELD; HEALTH PERSONNEL; HUMANS; INTENSIVE CARE UNITS; MICROBIAL SENSITIVITY TESTS; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS;

PSEUDOMONAS; PSEUDOMONAS AERUGINOSA;

EID: 14944344361     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.43.3.1198-1204.2005     Document Type: Article

References (32)

1. Bukholm, G., T. Tannaes, A. B. Kjelsberg, and N. Smith-Erichsen. 2002. An outbreak of multidrug-resistant Pseudomonas aeruginosa associated with increased risk of patient death in an intensive care unit. Infect. Control Hosp. Epidemiol. 23:441-446.
2. Cortes, P., D. Mariscal, J. Valles, J. Rello, and P. Coll. 2001. Presence of polyclonal Pseudomonas aeruginosa in an intensive care unit: a 27-month prospective study on molecular epidemiology. Infect. Control Hosp. Epidemiol. 22:720-723.
3. Doebbeling, B. N., M. A. Pfaller, A. K. Houston, and R. P. Wenzel. 1988. Removal of nosocomial pathogens from the contaminated glove. Implications for glove reuse and handwashing. Ann. Intern. Med. 109:394-398.
4. Foca, M., K. Jakob, S. Whittier, L. P. Della, S. Factor, D. Rubenstein, and L. Saiman. 2000. Endemic Pseudomonas aeruginosa infection in a neonatal intensive care unit. N. Engl. J. Med. 343:695-700.
5. Girlich, D., L. Poirel, A. Leelaporn, A. Karim, C. Tribuddharat, M. Fennewald, and P. Nordmann. 2001. Molecular epidemiology of the integron-located VEB-1 extended-spectrum beta-lactamase in nosocomial enterobacterial isolates in Bangkok, Thailand. J. Clin. Microbiol. 39:175-182.
6. Glupczynski, Y., M. Delmee, H. Goossens, and M. J. Struelens. 2001. Distribution and prevalence of antimicrobial resistance among gram-negative isolates in intensive care units (ICU) in Belgian hospitals between 1996 and 1999. Acta Clin. Belg. 56:297-306.
7. Grundmann, H., A. Kropec, D. Hartung, R. Berner, and F. Daschner. 1993. Pseudomonas aeruginosa in a neonatal intensive care unit: reservoirs and ecology of the nosocomial pathogen. J. Infect. Dis. 168:943-947.
8. Hocquet, D., X. Bertrand, T. Kohler, D. Talon, and P. Plesiat. 2003. Genetic and phenotypic variations of a resistant Pseudomonas aeruginosa epidemic clone. Antimicrob. Agents Chemother. 47:1887-1894.
9. Lagatolla, C., E. A. Tonin, C. Monti-Bragadin, L. Dolzani, F. Gombac, C. Bearzi, E. Edalucci, F. Gionechetti, and G. M. Rossolini. 2004. Endemic carbapenem-resistant Pseudomonas aeruginosa with acquired metallo-beta-lactamase determinants in European hospital. Emerg. Infect. Dis. 10:535-538.
10. Llanes, C., D. Hocquet, C. Vogne, D. Benali-Baitich, C. Neuwirth, and P. Plesiat. 2004. Clinical strains of Pseudomonas aeruginosa overproducing MexAB-OprM and MexXY efflux pumps simultaneously. Antimicrob. Agents Chemother. 48:1797-1802.
11. Mavroidi, A., A. Tsakris, E. Tzelepi, S. Pournaras, V. Loukova, and L. S. Tzouvelekis. 2000. Carbapenem-hydrolysing VIM-2 metallo- beta-lactamase in Pseudomonas aeruginosa from Greece. J. Antimicrob. Chemother. 46:1041-1042.
12. McNeil, S. A., L. Nordstrom-Lerner, P. N. Malani, M. Zervos, and C. A. Kauffman. 2001. Outbreak of sternal surgical site infections due to Pseudomonas aeruginosa traced to a scrub nurse with onychomycosis. Clin. Infect. Dis. 33:317-323.
13. Moolenaar, R. L., J. M. Crutcher, V. H. San Joaquin, L. V. Sewell, L. C. Hutwagner, L. A. Carson, D. A. Robison, L. M. Smithee, and W. R. Jarvis. 2000. A prolonged outbreak of Pseudomonas aeruginosa in a neonatal intensive care unit: did staff fingernails play a role in disease transmission? Infect. Control Hosp. Epidemiol. 21:80-85.
14. National Committee for Clinical Laboratory Standards. 2002. Methods for dilution antimicrobial susceptibility test for bacteria that grow aerobically, 5th ed. Approved standard M7-A5. National Committee for Clinical Laboratory Standards, Wayne, Pa.
15. Poirel, L., L. Collet, and P. Nordmann. 2000. Carbapenem-hydrolyzing metallo-beta-lactamase from a nosocomial isolate of Pseudomonas aeruginosa in France. Emerg. Infect. Dis. 6:84-85.
16. Poirel, L., O. Menuteau, N. Agoli, C. Cattoen, and P. Nordmann. 2003. Outbreak of extended-spectrum beta-lactamase VEB-1-producing isolates of Acinetobacter baumannii in a French hospital. J. Clin. Microbiol. 41:3542-3547.
17. Poirel, L., T. Naas, D. Nicolas, L. Collet, S. Bellais, J. D. Cavallo, and P. Nordmann. 2000. Characterization of VIM-2, a carbapenem-hydrolyzing metallo-beta-lactamase and its plasmid- and integron-borne gene from a Pseudomonas aeruginosa clinical isolate in France. Antimicrob. Agents Chemother. 44:891-897.
18. Poirel, L., G. F. Weldhagen, T. Naas, C. De Champs, M. G. Dove, and P. Nordmann. 2001. GES-2, a class A beta-lactamase from Pseudomonas aeruginosa with increased hydrolysis of imipenem. Antimicrob. Agents Chemother. 45:2598-2603.
19. Poole, K. 2004. Efflux-mediated multiresistance in Gram-negative bacteria. Clin. Microbiol. Infect. 10:12-26.
20. Scott, F. W., and T. L. Pitt. 2004. Identification and characterization of transmissible Pseudomonas aeruginosa strains in cystic fibrosis patients in England and Wales. J. Med. Microbiol. 53:609-615.
21. Speijer, H., P. H. Savelkoul, M. J. Bonten, E. E. Stobberingh, and J. H. Tjhie. 1999. Application of different genotyping methods for Pseudomonas aeruginosa in a setting of endemicity in an intensive care unit. J. Clin. Microbiol. 37:3654-3661.
22. Struelens, M. J., F. Rost, A. Deplano, A. Maas, V. Schwam, E. Serruys, and M. Cremer. 1993. Pseudomonas aeruginosa and Enterobacteriaceae bacteremia after biliary endoscopy: an outbreak investigation using DNA macrorestriction analysis. Am. J. Med. 95:489-498.
23. Talon, D., V. Cailleaux, M. Thouverez, and Y. Michel-Briand. 1996. Discriminatory power and usefulness of pulsed-field gel electrophoresis in epidemiological studies of Pseudomonas aeruginosa. J. Hosp. Infect. 32:135-145.
24. Tassios, P. T., V. Gennimata, A. N. Maniatis, C. Fock, and N. J. Legakis. 1998. Emergence of multidrug resistance in ubiquitous and dominant Pseudomonas aeruginosa serogroup O:11. The Greek Pseudomonas aeruginosa Study Group. J. Clin. Microbiol. 36:897-901.
25. Trautmann, M., T. Michalsky, H. Wiedeck, V. Radosavljevic, and M. Ruhnke. 2001. Tap water colonization with Pseudomonas aeruginosa in a surgical intensive care unit (ICU) and relation to Pseudomonas infections of ICU patients. Infect. Control Hosp. Epidemiol. 22:49-52.
26. Tsakris, A., P. T. Tassios, F. Polydorou, A. Papa, E. Malaka, A. Antoniadis, and N. J. Legakis. 2003. Infrequent detection of acquired metallo-beta-lactamases among carbapenem-resistant Pseudomonas isolates in a Greek hospital. Clin. Microbiol. Infect. 9:846-851.
27. Vincent, J. L. 2000. Microbial resistance: lessons from the EPIC study. European prevalence of infection. Intensive Care Med. 26(Suppl. 1):S3-S8.
28. Vincent, J. L., D. J. Bihari, P. M. Suter, H. A. Bruining, J. White, M. H. Nicolas-Chanoine, M. Wolff, R. C. Spencer, and M. Hemmer. 1995. The prevalence of nosocomial infection in intensive care units in Europe. Results of the European Prevalence of Infection in Intensive Care (EPIC) Study. EPIC International Advisory Committee. JAMA 274:639-644.
29. Vogne, C., J. R. Aires, C. Bailly, D. Hocquet, and P. Plesiat. 2004. Role of the multidrug efflux system MexXY in the emergence of moderate resistance to aminoglycosides among Pseudomonas aeruginosa isolates from patients with cystic fibrosis. Antimicrob. Agents Chemother. 48:1676-1680.
30. Walsh, T. R., A. Bolmstrom, A. Qwarnstrom, and A. Gales. 2002. Evaluation of a new E-test for detecting metallo-beta-lactamases in routine clinical testing. J. Clin. Microbiol. 40:2755-2759.
31. Wenzel, R. P. 1994. Healthcare workers and the incidence of nosocomial infection: can treatment of one influence the other? a brief review. J. Chemother. 6(Suppl. 4):33-37.
32. Widmer, A. F., R. P. Wenzel, A. Trilla, M. J. Bale, R. N. Jones, and B. N. Doebbeling. 1993, Outbreak of Pseudomonas aeruginosa infections in a surgical intensive care unit: probable transmission via hands of a health care worker. Clin. Infect. Dis. 16:372-376.